
Biological modification in cancer therapy involves many different strategies and zzso zzso products with established usefulness include zzso zzso zzso and zzso zzso with such agents has not, however, found general application, although revived interest in zzso mixed zzso zzso earlier this zzso paralleled the development of their presumed zzso zzso zzso necrosis factor and zzso Many other zzso both natural or zzso are now produced on a vast scale following the recent biotechnology zzso Of these, Alpha zzso have already proved useful in zzso cell zzso zzso zzso zzso cell cancer, zzso zzso chronic zzso zzso and certain zzso whilst their use as zzso or in combination is currently being zzso More recently, zzso which stimulates the zzso expansion of activated zzso has shown promise both as a single agent, and when used with zzso activated killer zzso cells or zzso zzso zzso zzso A different approach involves the Colony zzso zzso such as zzso and zzso which reduce the degree and duration of zzso zzso thereby allowing more intensive zzso or radiation therapy, as well as zzso early recovery following bone zzso zzso zzso zzso have not proved as specific for zzso cells as was originally hoped, but certain zzso such as lymphoma, are now realistic targets for zzso Increasingly sophisticated zzso mechanisms zzso zzso zzso and genetically engineered zzso zzso zzso hybrids present the brightest hopes for the zzso zzso the zzso zzso of cancer zzso has already assumed its place alongside surgery, zzso and zzso chemotherapy, and will grow in importance as our understanding of the molecular biology of cancer increases in the coming zzso 

